{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:18:50Z","timestamp":1781101130540,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.beha.2016.08.022","type":"journal-article","created":{"date-parts":[[2016,9,25]],"date-time":"2016-09-25T10:00:31Z","timestamp":1474797631000},"page":"156-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenomics in Waldenstrom's macroglobulinaemia"],"prefix":"10.1016","volume":"29","author":[{"given":"Antonio","family":"Sacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Fenotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Imberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2016.08.022_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beha.2016.08.022_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2007.01.023","article-title":"Timescales of genetic and epigenetic inheritance","volume":"128","author":"Rando","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beha.2016.08.022_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1073\/pnas.25.7.299","article-title":"Preliminary notes on the development of the wings in normal and mutant strains of Drosophila","volume":"25","author":"Waddington","year":"1939","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2016.08.022_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2010-01-265686","article-title":"microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia","volume":"116","author":"Roccaro","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.022_bib5","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood-2008-09-178228","article-title":"microRNA expression in the biology, prognosis, and therapy of Waldenstrom macroglobulinemia","volume":"113","author":"Roccaro","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.022_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.beha.2016.08.022_bib7","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","article-title":"MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior","volume":"24","author":"Roldo","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2016.08.022_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature03441","article-title":"Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals","volume":"434","author":"Xie","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.beha.2016.08.022_bib9","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1073\/pnas.0404432101","article-title":"MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2016.08.022_bib10","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2016.08.022_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cancergencyto.2007.10.008","article-title":"Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma","volume":"181","author":"Rai","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2016.08.022_bib12","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2012-02-410647","article-title":"LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.022_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.01.033","article-title":"The mammalian epigenome","volume":"128","author":"Bernstein","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beha.2016.08.022_bib14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/jnci\/djj447","article-title":"Epigenetic cancer therapy makes headway","volume":"98","author":"Mack","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.beha.2016.08.022_bib15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/1535-7163.MCT-15-0985-T","article-title":"Therapeutic targeting of miR-29b\/HDAC4 epigenetic loop in multiple myeloma","volume":"15","author":"Amodio","year":"2016","journal-title":"Molec Cancer Ther"},{"key":"10.1016\/j.beha.2016.08.022_bib16","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1038\/bcj.2015.38","article-title":"Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma","volume":"5","author":"Hideshima","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.beha.2016.08.022_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.clml.2013.03.016","article-title":"Histone deacetylase inhibitors in multiple myeloma: rationale and evidence for their use in combination therapy","volume":"13","author":"Kaufman","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.beha.2016.08.022_bib18","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2002-11-3514","article-title":"Molecular sequelae of histone deacetylase inhibition in human malignant B cells","volume":"101","author":"Mitsiades","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.022_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","article-title":"Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis","volume":"5","author":"Zhu","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2016.08.022_bib20","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1158\/1535-7163.MCT-05-0480","article-title":"Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells","volume":"5","author":"Hrzenjak","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.beha.2016.08.022_bib21","doi-asserted-by":"crossref","first-page":"34940","DOI":"10.1074\/jbc.274.49.34940","article-title":"Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects","volume":"274","author":"Sambucetti","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beha.2016.08.022_bib22","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1093\/emboj\/cdf616","article-title":"MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation","volume":"21","author":"Ito","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.beha.2016.08.022_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/86507","article-title":"Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes","volume":"7","author":"Kim","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2016.08.022_bib24","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1","volume":"113","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.022_bib25","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/onc.2009.19","article-title":"miR-449a targets HDAC-1 and induces growth arrest in prostate cancer","volume":"28","author":"Noonan","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2016.08.022_bib26","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2016.08.022_bib27","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Varambally","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.beha.2016.08.022_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2012-06-439307","article-title":"Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed\/refractory Waldenstrom macroglobulinemia","volume":"121","author":"Ghobrial","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.022_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7","article-title":"Histone deacetylases, transcriptional control, and cancer","volume":"184","author":"Cress","year":"2000","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.beha.2016.08.022_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF03402044","article-title":"Histone acetylation modifiers in the pathogenesis of malignant disease","volume":"6","author":"Mahlknecht","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/j.beha.2016.08.022_bib31","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/PL00000896","article-title":"Histone acetylation and disease","volume":"58","author":"Timmermann","year":"2001","journal-title":"Cell Molec Life Sci"},{"key":"10.1016\/j.beha.2016.08.022_bib32","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1093\/emboj\/19.15.4074","article-title":"Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway","volume":"19","author":"Urnov","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.beha.2016.08.022_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/(SICI)1097-4644(1998)72:30\/31+<194::AID-JCB24>3.0.CO;2-H","article-title":"Role of histone deacetylases in acute leukemia","volume":"30\u201331","author":"Fenrick","year":"1998","journal-title":"J\u00a0Cell Biochem Suppl"},{"key":"10.1016\/j.beha.2016.08.022_bib34","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/sj.onc.1204299","article-title":"Transcription therapy for cancer","volume":"20","author":"Pandolfi","year":"2001","journal-title":"Oncogene"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T20:24:10Z","timestamp":1568406250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692616300494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1521692616300494"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2016.08.022","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenomics in Waldenstrom's macroglobulinaemia","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2016.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}